BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36349793)

  • 1. Risk Factors of Rapid FEV1 Decline in a Real-World Chronic Obstructive Pulmonary Disease Cohort.
    Lee HW; Lee JK; Lee MG; Shin KC; Ra SW; Kim TH; Hwang YI; Jung KS; Yoo KH; Kim DK
    Respiration; 2022; 101(12):1078-1087. PubMed ID: 36349793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid FEV
    Choi KY; Lee HJ; Lee JK; Park TY; Heo EY; Kim DK; Lee HW
    J Korean Med Sci; 2023 Jan; 38(1):e4. PubMed ID: 36593688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in clinical significance of bronchodilator responses measured by forced expiratory volume in 1 second and forced vital capacity.
    Choi JY; Kim SK; Lee JH; Jung KS; Yoo KH; Hwang KE; Lee JD; Kim YI; Yoon HK; Um SJ
    PLoS One; 2023; 18(2):e0282256. PubMed ID: 36827406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical Characteristics and Frequency of Chronic Obstructive Pulmonary Disease Exacerbations in Korean Patients: Findings From the KOCOSS Cohort 2012-2021.
    Rhee CK; Choi JY; Park YB; Yoo KH
    J Korean Med Sci; 2024 May; 39(19):e164. PubMed ID: 38769923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of time profile of FEV
    Suzuki M; Matsumoto I; Ishida M; Horie Y; Ban H; Takeuchi W; Nakagawa S; Nakagawa T; Kitamura T; Muro S
    Sci Rep; 2023 Apr; 13(1):5454. PubMed ID: 37012340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Rapid Lung Function Decline in Young Adults With Chronic Obstructive Pulmonary Disease: A Community-Based Prospective Cohort Study.
    Kim SH; Lee H; Joo H; Choi H; Sim YS; Rhee CK; Park YB; Kim Y; Yoo KH
    J Korean Med Sci; 2023 Jan; 38(1):e3. PubMed ID: 36593687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
    Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
    Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid FEV
    Lee HW; Lee HJ; Lee JK; Park TY; Heo EY; Kim DK
    Chest; 2022 Aug; 162(2):466-474. PubMed ID: 35318007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure.
    Ramírez-Venegas A; Sansores RH; Quintana-Carrillo RH; Velázquez-Uncal M; Hernandez-Zenteno RJ; Sánchez-Romero C; Velazquez-Montero A; Flores-Trujillo F
    Am J Respir Crit Care Med; 2014 Nov; 190(9):996-1002. PubMed ID: 25172140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal lung volume changes in patients with chronic obstructive pulmonary disease.
    Lee JS; Kim SO; Seo JB; Lee JH; Kim EK; Kim TH; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Lee SW; Huh JW; Oh YM; Lee SD
    Lung; 2013 Aug; 191(4):405-12. PubMed ID: 23715996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.
    Nishimura M; Makita H; Nagai K; Konno S; Nasuhara Y; Hasegawa M; Shimizu K; Betsuyaku T; Ito YM; Fuke S; Igarashi T; Akiyama Y; Ogura S;
    Am J Respir Crit Care Med; 2012 Jan; 185(1):44-52. PubMed ID: 22016444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial load and related innate immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease.
    D'Anna SE; Dossena F; Gnemmi I; Brun P; Spanevello A; Carriero V; Bertolini F; Maniscalco M; Ricciardolo FL; Balbi B; Di Stefano A
    Respir Med; 2023; 215():107297. PubMed ID: 37245650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor use.
    Petersen H; Sood A; Meek PM; Shen X; Cheng Y; Belinsky SA; Owen CA; Washko G; Pinto-Plata V; Kelly E; Celli B; Tesfaigzi Y
    Chest; 2014 Apr; 145(4):695-703. PubMed ID: 24008986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients.
    Nagai K; Makita H; Suzuki M; Shimizu K; Konno S; Ito YM; Nishimura M;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():745-57. PubMed ID: 25914531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of Forced Expiratory Volume in One Second and Forced Expiratory Volume in One Second/Forced Vital Capacity Decline among Indonesian Patients with Chronic Obstructive Pulmonary Disease after a Year of Treatment.
    Ariawan WP; Yunus F; Damayanti T; Nurwidya F
    Int J Appl Basic Med Res; 2019; 9(2):95-99. PubMed ID: 31041172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics Associated with Accelerated Lung Function Decline in a Primary Care Population with Chronic Obstructive Pulmonary Disease.
    Whittaker HR; Pimenta JM; Jarvis D; Kiddle SJ; Quint JK
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3079-3091. PubMed ID: 33268984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ratio of FEV
    Fortis S; Comellas AP; Bhatt SP; Hoffman EA; Han MK; Bhakta NR; Paine R; Ronish B; Kanner RE; Dransfield M; Hoesterey D; Buhr RG; Barr RG; Dolezal B; Ortega VE; Drummond MB; Arjomandi M; Kaner RJ; Kim V; Curtis JL; Bowler RP; Martinez F; Labaki WW; Cooper CB; O'Neal WK; Criner G; Hansel NN; Krishnan JA; Woodruff P; Couper D; Tashkin D; Barjaktarevic I
    Chest; 2021 Jul; 160(1):94-103. PubMed ID: 33539837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis.
    Chen W; Sadatsafavi M; FitzGerald JM; Lynd LD; Sin DD
    Respir Res; 2021 Feb; 22(1):59. PubMed ID: 33602241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.